Comparison of immunoradiometric assays for determination of thyroglobulin: A validation study

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 3, 2007, Pages 147-153

  Tortajada Genaro, Luis Antonio ^a   Cozar M P ^b   Moreno Frigols, J L ^b   Romero De Avila, C ^b  

^a UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Analytical validation; Immunoradiometric assay; IRMA; Thyroglobulin

Indexed keywords

IODINE 125; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANTIBODY LABELING; ARTICLE; CALCULATION; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DILUTION; EVALUATION; FEMALE; HUMAN; IMAGE QUALITY; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; SAMPLING; THYROID CANCER; THYROID DISEASE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALIBRATION; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 34249287347     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20156     Document Type: Article

References (16)

1. Dunn JT. Clinical usefulness of serum thyroglobulin assays. In: Hamburger JI, editor. Diagnostic methods in clinical thyroidology. New York: Springer Verlag; 1989. p 127-157.
2. Schlumberger M, Pacini F, Wiersinga WM, et al. Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice. Eur J Endocrinol 2004;151:539-548.
3. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid. 1999;9:435-441.
4. Giammarile F, Hafdi Z, Bournaud C, et al. Is [18F]-2-fluoro-2-deoxy-d- glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake? Eur J Endocrinol 2003;149:293-300.
5. Ruiz Franco-Baux JV, Borrego Dorado I, Gomez Camarero P, et al. F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan. Rev Esp Med Nucl 2005;24:5-13.
6. Morgenthaler NG, Froehlich J, Rendl J, et al. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin. Clin Chem 2002;48:1077-1083.
7. Erali M, Bigelow RB, Meikle AW. ELISA for thyroglobulin in serum: recovery studies to evaluate autoantibody interference and reliability of thyroglobulin values. Clin Chem 1996;42:766-770.
8. Okosieme OE, Evans C, Moss L, Parkes AB, Premawardhana LD, Lazarus JH. Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem 2005;51:729-734.
9. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90:5566-5575.
10. Marquet PY, Daver A, Sapin R, et al. Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies. Clin Chem 1996;42:258-262.
11. Massart C, Maugendre D. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease. Clin Chem 2002;48:102-107.
12. Ferrari L, Seregni E, Aliberti G, et al. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas. Q J Nucl Med Mol Imaging 2004;48:237-242.
13. Giovanella L, Ceriani L, Garancini S. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management. Q J Nucl Med 2002;46:319-322.
14. Bourrel F, Hoff M, Regis H, Courriere P, Caron P. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests. Clin Chem Lab Med 1998;36:725-730.
15. Feldt-Rasmussen U, Profilis C, Colinet E, et al. Human thyroglobulin reference material (CRM 457). I: assessment of homogeneity, stability and immunoreactivity. Ann Biol Clin (Paris) 1996;54:337-342.
16. Campins P, Tortajada-Genaro LA, Messeguer S, Blasco F, Sevillano A, Molins C. Creatinine determination in urine samples by batchwise kinetic procedure and flow injection analysis using the Jaffe reaction: chemometric study. Talanta 2001;55:1079-1089.